April 28, 2020 / 12:14 PM / a month ago

BRIEF-Inovio Completes Enrollment In The Phase 1 U.S. Trial Of Ino-4800 For Covid-19 Dna Vaccine Interim Results Expected In June

April 28 (Reuters) - Inovio Pharmaceuticals Inc:

* INOVIO COMPLETES ENROLLMENT IN THE PHASE 1 U.S. TRIAL OF INO-4800 FOR COVID-19 DNA VACCINE; INTERIM RESULTS EXPECTED IN JUNE

* INOVIO PHARMACEUTICALS INC - INO-4800 PHASE 2/3 U.S. CLINICAL TRIAL BEING PREPARED TO START THIS SUMMER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below